Dare Bioscience, Inc. (DARE) vs Lantern Pharma Inc. (LTRN)
A side-by-side comparison of Dare Bioscience, Inc. and Lantern Pharma Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DARE
Dare Bioscience, Inc.
$0.83HealthcareDelayed quote: Oct 6, 2026, 10:23 AM EDT
LTRN
Lantern Pharma Inc.
$0.93HealthcareDelayed quote: Oct 6, 2026, 10:24 AM EDT
Total return — DARE vs LTRN
growth of $100 · dividends reinvested · last 6yDARE -93.3% (-36.3%/yr)LTRN -93.7% (-36.9%/yr)DARE compounded faster over this window
DARE LTRN
DARE vs LTRN: by the numbers
- •DARE is the larger company ($12M vs $12M market cap).
- •Both run net losses; LTRN's is the smaller (0.00% vs -804.37% net margin).
Metrics side by side
Valuation
| Metric | DARE | LTRN |
|---|---|---|
| P/S ratio | 9.12 | N/A |
Profitability
| Metric | DARE | LTRN |
|---|---|---|
| Gross margin | -137.55% | 0.00% |
| Operating margin | -1315.51% | 0.00% |
| Net margin | -804.37% | 0.00% |
| ROIC | -203.50% | -358.04% |
Growth (annualized)
| Metric | DARE | LTRN |
|---|---|---|
| Total return CAGR (5Y) | -46.35% | -37.05% |
Frequently asked
- How have DARE and LTRN total returns compared?
- Over the past 5 years, DARE delivered -46.35% and LTRN delivered -37.05% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.